GlaxoSmithKline said on Friday European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan.
Read more
Reuters – GSK diabetes drug set ‘Eperzan’ for European approval
Posted in Drugs